Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old
Apply
ShigETEC
Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step